Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma

Clinical trial NCT05507658 · COMPLETED

Trial details

NCT number: NCT05507658
Sponsor: Xijing Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Gastric Adenocarcinoma

Start date: 2022-07-18
Primary completion: 2023-07-02
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.